way 100135 has been researched along with sincalide in 1 studies
Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (sincalide) | Trials (sincalide) | Recent Studies (post-2010) (sincalide) |
---|---|---|---|---|---|
143 | 0 | 34 | 4,015 | 72 | 533 |
Protein | Taxonomy | way 100135 (IC50) | sincalide (IC50) |
---|---|---|---|
Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0006 | |
Cholecystokinin receptor type A | Homo sapiens (human) | 0.0006 | |
Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 | |
Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | 0.0008 | |
Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.0004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bickerdike, MJ; Fletcher, A; Marsden, CA | 1 |
1 other study(ies) available for way 100135 and sincalide
Article | Year |
---|---|
Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Behavior, Animal; Cholecystokinin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Peptide Fragments; Piperazines; Pyridines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Sincalide; Time Factors | 1995 |